|
Monday, March 26 — 1:00 PM — CC 1 A/B
Click on the blue numbers in parentheses to display abstracts.
Click the  button next to any title to add to Itinerary Planner...
...then notice the 'Event Added' prompt
in the toolbar above as feedback: | |  |
|
Section C - GYNECOLOGIC PATHOLOGY
Chaired by: Charles Zaloudek and Bradley Quade
| Time | Title and Authors | Itinerary
Planner |
| 1:00 |
Distinction of Primary and Metastatic/Secondary Mucinous Tumors Involving the Ovary: Performance of the Tumor Laterality and Size Algorithm in Diagnosis of 169 Rigorously Classified Tumors Categorized by Primary Site
(1002)
A Yemelyanova, R Vang, K Judson, BM Ronnett The Johns Hopkins Hospital, Baltimore, MD
|  Add |
| 1:15 |
Advanced Stage Mucinous Carcinomas of the Ovary Are Very Rare and Highly Lethal
(1003)
RJ Zaino, M Brady, S Lele, H Michael Hershey Med Ctr, Hershey, PA; Gynecologic Oncology Group, Buffalo, NY; U of Nebraska Med Ctr, Omaha, NE; Indiana Univ Med Ctr, Indianapolis, IN
| Add |
| 1:30 |
Serous Borderline Tumors Represent a Biphasic Population Different from Invasive Serous Carcinomas of the Ovary
(964)
PK Puri, AM Schwartz, DE Henson George Washington University Medical Center, Washington, DC
| Add |
| 1:45 |
Frequent LOH at Chromosome 1p36 in Ovarian Serous Borderline Tumors
(945)
TL Mao, RJ Kurman, TL Wang, IM Shih Johns Hopkins Medical Institutions, Baltimore, MD; National Taiwan University Hospital, Taipei, Taiwan
| Add |
| 2:00 |
Evidence Supporting the Fimbria as One Site of Origin for Concurrent Ovarian and Endometrial Serous Carcinomas
(922)
EA Jarboe, M Hirsch, CP Crum, D Kindelberger, GL Mutter, MR Nucci Brigham and Women's Hospital, Boston, MA
| Add |
| 2:15 |
Type and Degree of T Cell Immune Response to Ovarian Carcinoma Matters: Correlation of Cytotoxic T Cells and Foxp3+ Immunosuppressive Tregs with Survival
(855)
KH Allison, CA Shah, RL Garcia, HJ Gray, C DelloRusso, EM Swisher University of Washington, Seattle, WA
| Add |
| 2:30 |
Identifying Candidate Signalling Pathways That Confer Resistance to Therapy from Gene Expression Array Data for Ovarian Cancer
(891)
ME Edgerton, DH Fisher, Z Chen, JM Lancaster MD Anderson Cancer Center, Houston, TX; Vanderbilt University, Nashville, TN; H. Lee Moffitt Cancer Center, Tampa, FL
| Add |
| 2:45 |
14-3-3 sigma Protein Expression in Ovarian Sex-Cord Stromal Neoplasms: An Immunohistochemical Study of 60 Cases
(876)
L Chen, W Liu, B Yang Cleveland Clinic, Cleveland, OH; Case Western Reserve University, Cleveland, OH
| Add |
| 3:00 |
RECESS, EXHIBITS, POSTER SESSION II
Coffee Break sponsored by US Labs
| |
| 4:30 |
NATHAN KAUFMAN TIMELY TOPICS LECTURE
Steven L. Kunkel, Ph.D.
Inflammatory Keys to Chronic Disease
Convention Center Room 6 A/B/C/F
| Add |
|
|
